| RQP74118 | |
| I. Background | |
| BTLA is a glycoprotein containing immunoglobulin domains, which is expressed on T cells, dormant B cells, macrophages, dendritic cells and a small number of NK cells. | |
| II. Introduction | |
| Expressed gene: | BTLA |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Synonym(s): | BTLA |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin |
| Mycoplasma Testing: | Negative |
| Storage: | Liquid nitrogen |
| III. Representative Data | |
Figure 1. Recombinant BTLA Effector Reporter Cell constitutively expressing BTLA.
Figure 2. Dose Response of BTLA Blocking Antibody in BTLAEffector Reporter Cells (Clone 1) With HVEM/ TCR Activator - CHO Cells.
Figure 3. Dose Response of HVEM Blocking Antibody in BTLA Effector Reporter Cells (Clone 1)With HVEM/TCR Activator - CHO Cells.
Figure 4. Dose Response of BTLA Agonist Abs in BTLA Effector Reporter Cells With FCγR aAPC Cells. | |
E-mail：sales@reqbio.com
Add:3rd Floor, No. 6, Lane 222,
Guangdan Road, Pudong New Area,
Shanghai，China
WeChat public account
